CLINICAL TRIALS

Sildenafil for Erectile Dysfunction

Double-Blind, Randomized, Placebo Controlled Trial of Sildenafil for the Treatment of Erectile Dysfunction in Patients with Cirrhosis

IRB Number :

Trial Status :

Open for Enrollment Phase: IV

Why is this study being done?

Sildenafil is phosphodiesterase inhibitor approved for the treatment of erectile dysfunction. However, the safety and efficacy of sildenafil in patients with cirrhosis and portal hypertension remains unknown. Positive results are anticipated to result in a novel therapy for eretcile dysfunction which is a common problem and negative influence on health-related quality of life in patients with cirrhosis.

Who is Eligible to Participate in the Study?

Male patients with a diagnosis of cirrhosis may be eligible.

Minimum Age:

18 years

Who can I Contact for Additional Information on this Trial?

Call Michelle Evjen at 507-266-0111 or Patrick S. Kamath, M.D.at 507-284-1649 Division of Gastroenterology & Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, MN, 55905

What is/are the Locations of this Clinical Trial?

Rochester, MN